3,883
edits
Changes
Jump to navigation
Jump to search
Line 2,103:
Line 2,103: + + + + − | || ||+ − |+ − |+ − |+ − | ||+ − |+ − |+ − + + + − + − | || − + − |+ − |+ − |+ − | ||+ − |+ − |+ + + + + + − + + + + + + − + − | − | − + + + + − + + + − |- − | || || − | || − + − | || − |- − | || || + + + − | || − |- − | || || − + + − |- − | || || − | || − + + + − | || − + + − + + + + + − + − | || || + + + + + − + + + − + − | || − + − + − ==WHO Classification of Soft Tissue and Bone Tumours (5th Edition) Content== − {| class="wikitable" − !'''Disease'''!!'''Page Type'''!!'''Author'''+ − !'''Date Assigned to Author'''+ − !'''Target Completion Date'''+ − !'''Author Content (Pending or Complete)'''+ − !'''Date Completed by Author'''!!'''Associate Editor'''+ − !'''Date of Last Editor Review'''+ − !'''Notes'''+ + − + − + + + − |PENDING − |Alanna Church − + − + − ==WHO Classification of Tumours of the Central Nervous System (5th Edition) Content== − {| class="wikitable" − − !'''Disease'''!!'''Page Type'''!!'''Author''' − !'''Date Assigned to Author''' − !'''Target Completion Date''' − !'''Author Content (Pending or Complete)''' − !'''Date Completed by Author'''!!'''Associate Editor''' − !'''Date of Last Editor Review''' − !'''Notes''' − − |Astrocystoma, IDH-Mutant − |Disease − − − |PENDING − |Laveniya Satgunaseelan (LS) − |2021 template added − |- − |Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted||Disease||Riley Lochner (trainee), Shashi Shetty (mentor) − |3/3/2022 − |PENDING − |Laveniya Satgunaseelan (LS) − |2021 template added − + Line 2,279:
Line 2,275: − + Line 2,288:
Line 2,284: − + Line 2,297:
Line 2,293: − + + + + + + + + + + Line 2,306:
Line 2,311: − + Line 2,315:
Line 2,320: − + − |PENDING − |LS − |2021 template added − |- − |Diffuse Hemispheric Glioma, H3 G34-Mutant||Disease||Xiaolin (Lynn) Hu − |2/21/2022 − |PENDING − |LS − |2021 template added − + − + − |PENDING − |LS − |2021 template added − |- − |Infant-Type Hemispheric Glioma||Disease|| + + + − |2021 template added − |- − |Pilocytic Astrocytoma||Disease||Jeremy Pulvers − |9/13/2022<br /> − |PENDING − |LS − |2021 template added − + Line 2,369:
Line 2,356: − + Line 2,378:
Line 2,365: − + Line 2,387:
Line 2,374: − + Line 2,396:
Line 2,383: − + Line 2,405:
Line 2,392: − + − |6/30/2022 − | − |COMPLETE − | − |LS − | − |2021 template added − |- − |Gangliocytoma||Disease|| Line 2,423:
Line 2,401: − + Line 2,432:
Line 2,410: − + Line 2,441:
Line 2,419: − + Line 2,450:
Line 2,428: − + Line 2,459:
Line 2,437: − + Line 2,468:
Line 2,446: − + Line 2,477:
Line 2,455: − + Line 2,486:
Line 2,464: − + Line 2,495:
Line 2,473: − + Line 2,504:
Line 2,482: − + Line 2,513:
Line 2,491: − + Line 2,522:
Line 2,500: − + Line 2,531:
Line 2,509: − + Line 2,540:
Line 2,518: − + Line 2,549:
Line 2,527: − + Line 2,558:
Line 2,536: − + + + + + + + + + + Line 2,567:
Line 2,554: − + Line 2,576:
Line 2,563: − + Line 2,585:
Line 2,572: − + Line 2,594:
Line 2,581: − + Line 2,603:
Line 2,590: − + Line 2,612:
Line 2,599: − + Line 2,621:
Line 2,608: − + Line 2,630:
Line 2,617: − + Line 2,639:
Line 2,626: − + Line 2,648:
Line 2,635: − + − |9/20/21 − | − |COMPLETE − | − |Holli Drendel (interim)/Laveniya Satgunaseelan (LS) − |9/22/2022 − |2021 template added − |- − |Medulloblastoma, SHH-Activated and TP53-Wildtype||Disease|| Line 2,666:
Line 2,644: − + Line 2,675:
Line 2,653: − + Line 2,684:
Line 2,662: − + Line 2,693:
Line 2,671: − + Line 2,702:
Line 2,680: − + Line 2,711:
Line 2,689: − + Line 2,720:
Line 2,698: − + Line 2,729:
Line 2,707: − + Line 2,738:
Line 2,716: − + Line 2,747:
Line 2,725: − + Line 2,756:
Line 2,734: − + Line 2,765:
Line 2,743: − + Line 2,774:
Line 2,752: − + Line 2,783:
Line 2,761: − + Line 2,792:
Line 2,770: − + Line 2,801:
Line 2,779: − + Line 2,810:
Line 2,788: − + Line 2,819:
Line 2,797: − + Line 2,828:
Line 2,806: − + Line 2,837:
Line 2,815: − + Line 2,846:
Line 2,824: − + Line 2,855:
Line 2,833: − + Line 2,864:
Line 2,842: − + Line 2,873:
Line 2,851: − + Line 2,882:
Line 2,860: − + Line 2,891:
Line 2,869: − + Line 2,900:
Line 2,878: − + Line 2,909:
Line 2,887: − + Line 2,918:
Line 2,896: − + Line 2,927:
Line 2,905: − + Line 2,936:
Line 2,914: − + Line 2,945:
Line 2,923: − + Line 2,954:
Line 2,932: − + Line 2,963:
Line 2,941: − + Line 2,972:
Line 2,950: − + Line 2,981:
Line 2,959: − + Line 2,990:
Line 2,968: − + Line 2,999:
Line 2,977: − + Line 3,008:
Line 2,986: − + Line 3,017:
Line 2,995: − + Line 3,026:
Line 3,004: − + Line 3,035:
Line 3,013: − + Line 3,044:
Line 3,022: − + Line 3,053:
Line 3,031: − + Line 3,062:
Line 3,040: − + Line 3,071:
Line 3,049: − + Line 3,080:
Line 3,058: − + Line 3,089:
Line 3,067: − + Line 3,098:
Line 3,076: − + Line 3,107:
Line 3,085: − + Line 3,116:
Line 3,094: − + Line 3,125:
Line 3,103: − + Line 3,134:
Line 3,112: − + Line 3,143:
Line 3,121: − + Line 3,152:
Line 3,130: − + Line 3,161:
Line 3,139: − + Line 3,170:
Line 3,148: − + Line 3,179:
Line 3,157: − + Line 3,188:
Line 3,166: − + Line 3,197:
Line 3,175: − + Line 3,206:
Line 3,184: − + Line 3,215:
Line 3,193: − + Line 3,224:
Line 3,202: − + Line 3,233:
Line 3,211: − + Line 3,242:
Line 3,220: − + Line 3,251:
Line 3,229: − + − + − + − + − + + + + + + + + + + + + + + − + + + + + + + + + + + + + + + + + + + + + + + + Line 3,269:
Line 3,283: − + Line 3,278:
Line 3,292: − + Line 3,287:
Line 3,301: − + Line 3,296:
Line 3,310: − + Line 3,305:
Line 3,319: − + Line 3,314:
Line 3,328: − + Line 3,323:
Line 3,337: − + Line 3,332:
Line 3,346: − + Line 3,341:
Line 3,355: − + − ==WHO Classification of Tumours of Breast Tumours (5th Edition) Content==+ − {| class="wikitable" − |- − !'''Disease'''!!'''Page Type'''!!'''Author''' − !'''Date Assigned to Author''' − !'''Target Completion Date''' − !'''Author Content (Pending or Complete)''' − !'''Date Completed by Author'''!!'''Associate Editor''' − !'''Date of Last Editor Review''' − !'''Notes''' − |- − |Adenoid Cystic Carcinoma − − − |PENDING − |Hui Chen − |2021 template added − |- − |Secretory Carcinoma − |Disease − |Hui Chen − |10/12/2022 − |PENDING − |Katherine Geiersbach − |2021 template added − |- − |}<br /> − − ==WHO Breast tumours (5th ed.) Content== − {| class="wikitable" − !'''Disease'''!!'''Page Type'''!!'''Author'''+ − !'''Date Assigned to Author''' − !'''Target Completion Date''' − !'''Author Content (Pending or Complete)''' − !'''Date Completed by Author'''!!'''Associate Editor''' − !'''Date of Last Editor Review''' − !'''Notes''' − Line 3,395:
Line 3,373: − + Line 3,404:
Line 3,382: − + Line 3,413:
Line 3,391: − + Line 3,422:
Line 3,400: − + Line 3,431:
Line 3,409: − + Line 3,440:
Line 3,418: − + Line 3,449:
Line 3,427: − + Line 3,458:
Line 3,436: − + Line 3,467:
Line 3,445: − + Line 3,476:
Line 3,454: − + Line 3,485:
Line 3,463: − + Line 3,494:
Line 3,472: − + Line 3,503:
Line 3,481: − + Line 3,512:
Line 3,490: − + Line 3,521:
Line 3,499: − + Line 3,530:
Line 3,508: − + Line 3,539:
Line 3,517: − + Line 3,548:
Line 3,526: − + Line 3,557:
Line 3,535: − + Line 3,566:
Line 3,544: − + Line 3,575:
Line 3,553: − + Line 3,584:
Line 3,562: − + Line 3,593:
Line 3,571: − + Line 3,602:
Line 3,580: − + Line 3,611:
Line 3,589: − + Line 3,620:
Line 3,598: − + Line 3,629:
Line 3,607: − + Line 3,638:
Line 3,616: − + Line 3,647:
Line 3,625: − + Line 3,656:
Line 3,634: − + Line 3,665:
Line 3,643: − + Line 3,674:
Line 3,652: − + Line 3,683:
Line 3,661: − + Line 3,692:
Line 3,670: − + Line 3,701:
Line 3,679: − + Line 3,710:
Line 3,688: − + Line 3,719:
Line 3,697: − + Line 3,728:
Line 3,706: − + Line 3,737:
Line 3,715: − + Line 3,746:
Line 3,724: − + Line 3,755:
Line 3,733: − + Line 3,764:
Line 3,742: − + Line 3,773:
Line 3,751: − + Line 3,782:
Line 3,760: − + Line 3,791:
Line 3,769: − + Line 3,800:
Line 3,778: − + Line 3,809:
Line 3,787: − + Line 3,818:
Line 3,796: − + Line 3,827:
Line 3,805: − + Line 3,836:
Line 3,814: − + Line 3,845:
Line 3,823: − + Line 3,854:
Line 3,832: − + Line 3,863:
Line 3,841: − + Line 3,872:
Line 3,850: − + Line 3,881:
Line 3,859: − + Line 3,890:
Line 3,868: − + Line 3,899:
Line 3,877: − + Line 3,908:
Line 3,886: − + Line 3,917:
Line 3,895: − + Line 3,926:
Line 3,904: − + Line 3,935:
Line 3,913: − + Line 3,944:
Line 3,922: − + Line 3,953:
Line 3,931: − + Line 3,962:
Line 3,940: − + Line 3,971:
Line 3,949: − + Line 3,980:
Line 3,958: − + Line 3,989:
Line 3,967: − + Line 3,998:
Line 3,976: − + Line 4,007:
Line 3,985: − + Line 4,016:
Line 3,994: − + Line 4,025:
Line 4,003: − |Invasive carcinoma||Disease||+ − | − | − | − | − | − | − | − |- − |Metastases to the breast||Disease|| − | − | − | − | − | − | − | − |- − |BRCA1/2-associated hereditary breast and ovarian cancer syndrome||Disease|| − | − | − | − | − | − | − | − |- − |Cowden syndrome||Disease|| − | − | − | − | − | − | − | − |- − |Ataxia-telangiectasia||Disease|| − | − | − | − | − | − | − | − |- − |Li-Fraumeni syndrome, TP53-associated||Disease|| − | − | − | − | − | − | − | − |- − |Li-Fraumeni syndrome, CHEK2-associated||Disease|| − | − | − | − | − | − | − | − |- − |CDH1-associated breast cancer||Disease|| − | − | − | − | − | − | − | − |- − |PALB2-associated cancers||Disease|| − | − | − | − | − | − | − | − |- − |Peutz-Jeghers syndrome||Disease|| − | − | − | − | − | − | − | − |- −
Volunteer Assignments and Opportunities (view source)
Revision as of 16:42, 22 January 2023
, 16:42, 22 January 2023no edit summary
|
|
|
|
|}<br />
==WHO Classification of Soft Tissue and Bone Tumours (5th Edition) Content==
{| class="wikitable"
|-
|-
!'''Disease'''!!'''Page Type'''!!'''Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|-
| || ||
|NTRK-Rearranged Spindle Cell Neoplasm||Disease||James Solomon, MD, PhD
|2/20/2022
|
|
|PENDING
|
|
|
|Alanna Church
|
|
|
|
|-
|-
| || ||
|}<br />
==WHO Classification of Tumours of the Central Nervous System (5th Edition) Content==
{| class="wikitable"
|-
!'''Disease'''!!'''Page Type'''!!'''Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|-
| || ||
|Astrocystoma, IDH-Mutant
|Disease
|Riley Lochner (trainee), Shashi Shetty (mentor)
|3/3/2022
|
|
|PENDING
|
|
|Laveniya Satgunaseelan (LS)
|
|
| ||
|2021 template added
|-
|-
| || ||
|Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted||Disease||Riley Lochner (trainee), Shashi Shetty (mentor)
|3/3/2022
|
|
|PENDING
|
|
|Laveniya Satgunaseelan (LS)
|
|
| ||
|2021 template added
|-
|Glioblastoma, IDH-Wildtype||Disease||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|-
| || ||
|Diffuse Astrocytoma, MYB- or MYBL1-Altered||Disease||
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|Angiocentric Glioma||Disease||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||
|-
|Polymorphous Low-Grade Neuroepithelial Tumour of the Young||Disease||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|-
| || ||
|Diffuse Low-Grade Glioma, MAPK Pathway-Altered||Disease||
|
|
|
|
|
|
|
|
|
|
|
|
|-
|-
| || ||
|Diffuse Midline Glioma, H3 K27-Altered||Disease||Laveniya Satgunaseelan (Linda Cooley - previous version)
|
|
|
|
|PENDING
|
|
| ||
|LS
|
|
|2021 template added
|-
|Diffuse Hemispheric Glioma, H3 G34-Mutant||Disease||Xiaolin (Lynn) Hu
|2/21/2022
|
|
|-
|PENDING
|
|
|LS
|
|
|2021 template added
|-
|Diffuse Paediatric-Type High-Grade Glioma, H3-Wildtype and IDH-Wildtype||Disease||Madina Sukhanova
|10/28/2022
|
|
| ||
|PENDING
|
|
|LS
|
|
|2021 template added
|-
|-
| || ||
|Infant-Type Hemispheric Glioma||Disease||
|
|
|
|
|
|
|
|
|
|
|}<br />
|
|2021 template added
|-
|-
|Pilocytic Astrocytoma||Disease||Jeremy Pulvers
|9/13/2022<br />
|
|PENDING
|
|LS
|
|2021 template added
|-
|-
|NTRK-Rearranged Spindle Cell Neoplasm||Disease||James Solomon, MD, PhD
|High-Grade Astrocytoma with Piloid Features||Disease||
|2/20/2022
|
|
|
|
|
|
|
|
|
|
|
|-
|-
|}<br />
|Pleomorphic Xanthoastrocytoma||Disease||
|
|-
|-
|Riley Lochner (trainee), Shashi Shetty (mentor)
|3/3/2022
|
|
|
|
|
|
|
|
|
|
|
|
|-
|-
|Glioblastoma, IDH-Wildtype||Disease||
|Subependymal Giant Cell Astrocytoma||Disease||
|
|
|
|
|
|
|-
|-
|Diffuse Astrocytoma, MYB- or MYBL1-Altered||Disease||
|Chordoid Glioma||Disease||
|
|
|
|
|
|
|-
|-
|Angiocentric Glioma||Disease||
|Astroblastoma, MN1-Altered||Disease||
|
|
|
|
|
|
|-
|-
|Polymorphous Low-Grade Neuroepithelial Tumour of the Young||Disease||
|Ganglioglioma||Disease||Leila Moayed-Aloei
|6/30/2022
|
|COMPLETE
|
|LS
|
|2021 template added
|-
|Gangliocytoma||Disease||
|
|
|
|
|
|
|-
|-
|Diffuse Low-Grade Glioma, MAPK Pathway-Altered||Disease||
|Desmoplastic Infantile Ganglioglioma/Desmoplastic Infantile Astrocytoma||Disease||
|
|
|
|
|
|
|-
|-
|Diffuse Midline Glioma, H3 K27-Altered||Disease||Laveniya Satgunaseelan (Linda Cooley - previous version)
|Dysembryoplastic Neuroepithelial Tumour||Disease||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|-
|Diffuse Paediatric-Type High-Grade Glioma, H3-Wildtype and IDH-Wildtype||Disease||Madina Sukhanova
|Diffuse Glioneuronal Tumour with Oligodendroglioma-Like Features and Nuclear Clusters||Disease||
|10/28/2022
|
|
|
|
|
|
|
|
|
|
|
|
|-
|Papillary Glioneuronal Tumour||Disease||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|-
|High-Grade Astrocytoma with Piloid Features||Disease||
|Rosette-Forming Glioneuronal Tumour||Disease||
|
|
|
|
|
|
|-
|-
|Pleomorphic Xanthoastrocytoma||Disease||
|Myxoid Glioneuronal Tumour||Disease||
|
|
|
|
|
|
|-
|-
|Subependymal Giant Cell Astrocytoma||Disease||
|Diffuse Lptomeningeal Glioneuronal Tumour||Disease||
|
|
|
|
|
|
|-
|-
|Chordoid Glioma||Disease||
|Multinodular and Vacuolating Neuronal Tumour||Disease||
|
|
|
|
|
|
|-
|-
|Astroblastoma, MN1-Altered||Disease||
|Dysplastic Cerebellar Gangliocytoma (Lhermitte-Duclos Disease)||Disease||
|
|
|
|
|
|
|-
|-
|Ganglioglioma||Disease||Leila Moayed-Aloei
|Central Neurocytoma||Disease||
|
|
|
|
|
|
|-
|-
|Desmoplastic Infantile Ganglioglioma/Desmoplastic Infantile Astrocytoma||Disease||
|Extraventricular Neurocytoma||Disease||
|
|
|
|
|
|
|-
|-
|Dysembryoplastic Neuroepithelial Tumour||Disease||
|Cerebellar Liponeurocytoma||Disease||
|
|
|
|
|
|
|-
|-
|Diffuse Glioneuronal Tumour with Oligodendroglioma-Like Features and Nuclear Clusters||Disease||
|Supratentorial Ependymoma||Disease||
|
|
|
|
|
|
|-
|-
|Papillary Glioneuronal Tumour||Disease||
|Supratentorial Ependymoma, ZFTA Fusion-Positive||Disease||
|
|
|
|
|
|
|-
|-
|Rosette-Forming Glioneuronal Tumour||Disease||
|Supratentorial Ependymoma, YAP1 Fusion-Positive||Disease||
|
|
|
|
|
|
|-
|-
|Myxoid Glioneuronal Tumour||Disease||
|Posterior Fossa Ependymoma||Disease||
|
|
|
|
|
|
|-
|-
|Diffuse Lptomeningeal Glioneuronal Tumour||Disease||
|Posterior Fossa Group A (PFA) Ependymoma||Disease||
|
|
|
|
|
|
|-
|-
|Multinodular and Vacuolating Neuronal Tumour||Disease||
|Posterior Fossa Group B (PFB) Ependymoma||Disease||
|
|
|
|
|
|
|-
|-
|Dysplastic Cerebellar Gangliocytoma (Lhermitte-Duclos Disease)||Disease||
|Spinal Ependymoma||Disease||
|
|
|
|
|
|
|-
|-
|Central Neurocytoma||Disease||
|Spinal Ependymoma, MYCN-Amplified||Disease||
|
|
|
|
|
|
|-
|-
|Extraventricular Neurocytoma||Disease||
|Myxopapillary Ependymoma||Disease||
|
|
|
|
|
|
|-
|-
|Cerebellar Liponeurocytoma||Disease||
|Subependymoma||Disease||
|
|
|
|
|
|
|-
|-
|Supratentorial Ependymoma||Disease||
|Choroid Plexus Papilloma||Disease||
|
|
|
|
|
|
|-
|-
|Supratentorial Ependymoma, ZFTA Fusion-Positive||Disease||
|Atypical Choroid Plexus Papilloma||Disease||
|
|
|
|
|
|
|-
|-
|Supratentorial Ependymoma, YAP1 Fusion-Positive||Disease||
|Choroid Plexus Carcinoma||Disease||
|
|
|
|
|
|
|-
|-
|Posterior Fossa Ependymoma||Disease||
|Medulloblastoma, WNT-Activated||Disease||Lisa Lansdon, PhD (LGG trainee just finished), Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City
|9/20/21
|
|COMPLETE
|
|Holli Drendel (interim)/Laveniya Satgunaseelan (LS)
|9/22/2022
|2021 template added
|-
|Medulloblastoma, SHH-Activated and TP53-Wildtype||Disease||
|
|
|
|
|
|
|-
|-
|Posterior Fossa Group A (PFA) Ependymoma||Disease||
|Medulloblastoma, SHH-Activated and TP53-Mutant||Disease||
|
|
|
|
|
|
|-
|-
|Posterior Fossa Group B (PFB) Ependymoma||Disease||
|Medulloblastoma, Non-WNT/Non-SHH||Disease||
|
|
|
|
|
|
|-
|-
|Spinal Ependymoma||Disease||
|Medulloblastoma, Histologically Defined||Disease||
|
|
|
|
|
|
|-
|-
|Spinal Ependymoma, MYCN-Amplified||Disease||
|Atypical Teratoid/Rhabdoid Tumour||Disease||
|
|
|
|
|
|
|-
|-
|Myxopapillary Ependymoma||Disease||
|Cribriform Neuroepithelial Tumour||Disease||
|
|
|
|
|
|
|-
|-
|Subependymoma||Disease||
|Embryonal Tumour with Multilayered Rosettes||Disease||
|
|
|
|
|
|
|-
|-
|Choroid Plexus Papilloma||Disease||
|CNS Neuroblastoma, FOXR2-Activated||Disease||
|
|
|
|
|
|
|-
|-
|Atypical Choroid Plexus Papilloma||Disease||
|CNS Tumour with BCOR Internal Tandem Duplication||Disease||
|
|
|
|
|
|
|-
|-
|Choroid Plexus Carcinoma||Disease||
|CNS Embryonal Tumour NEC/NOS||Disease||
|
|
|
|
|
|
|-
|-
|Medulloblastoma, WNT-Activated||Disease||Lisa Lansdon, PhD (LGG trainee just finished), Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City
|Pineocytoma||Disease||
|
|
|
|
|
|
|-
|-
|Medulloblastoma, SHH-Activated and TP53-Mutant||Disease||
|Pineal Parenchymal Tumour of Intermediate Differentiation||Disease||
|
|
|
|
|
|
|-
|-
|Medulloblastoma, Non-WNT/Non-SHH||Disease||
|Pineoblastoma||Disease||
|
|
|
|
|
|
|-
|-
|Medulloblastoma, Histologically Defined||Disease||
|Papillary Tumour of the Pineal Region||Disease||
|
|
|
|
|
|
|-
|-
|Atypical Teratoid/Rhabdoid Tumour||Disease||
|Desmoplastic Myxoid Tumour of the Pineal Region, SMARCB1-Mutant||Disease||
|
|
|
|
|
|
|-
|-
|Cribriform Neuroepithelial Tumour||Disease||
|Schwannoma||Disease||
|
|
|
|
|
|
|-
|-
|Embryonal Tumour with Multilayered Rosettes||Disease||
|Neurofibroma||Disease||
|
|
|
|
|
|
|-
|-
|CNS Neuroblastoma, FOXR2-Activated||Disease||
|Perineurioma||Disease||
|
|
|
|
|
|
|-
|-
|CNS Tumour with BCOR Internal Tandem Duplication||Disease||
|Hybrid Nerve Sheath Tumours||Disease||
|
|
|
|
|
|
|-
|-
|CNS Embryonal Tumour NEC/NOS||Disease||
|Malignant Melanotic Nerve Sheath Tumour||Disease||
|
|
|
|
|
|
|-
|-
|Pineocytoma||Disease||
|Malignant Peripheral Nerve Sheath Tumour||Disease||
|
|
|
|
|
|
|-
|-
|Pineal Parenchymal Tumour of Intermediate Differentiation||Disease||
|Cauda Equina Neuroendocrine Tumour (Previously Paraganglioma)||Disease||
|
|
|
|
|
|
|-
|-
|Pineoblastoma||Disease||
|Meningioma||Disease||
|
|
|
|
|
|
|-
|-
|Papillary Tumour of the Pineal Region||Disease||
|Solitary Fibrous Tumour||Disease||
|
|
|
|
|
|
|-
|-
|Desmoplastic Myxoid Tumour of the Pineal Region, SMARCB1-Mutant||Disease||
|Haemangiomas and Vascular Malformations||Disease||
|
|
|
|
|
|
|-
|-
|Schwannoma||Disease||
|Haemangioblastoma||Disease||
|
|
|
|
|
|
|-
|-
|Neurofibroma||Disease||
|Rhabdomyosarcoma||Disease||
|
|
|
|
|
|
|-
|-
|Perineurioma||Disease||
|Intracranial Mesenchymal Tumour, FET::CREB Fusion-Positive||Disease||
|
|
|
|
|
|
|-
|-
|Hybrid Nerve Sheath Tumours||Disease||
|CIC-Rearranged Sarcoma||Disease||
|
|
|
|
|
|
|-
|-
|Malignant Melanotic Nerve Sheath Tumour||Disease||
|Primary Intracranial Sarcoma, DICER1-Mutant||Disease||
|
|
|
|
|
|
|-
|-
|Malignant Peripheral Nerve Sheath Tumour||Disease||
|Ewing Sarcoma||Disease||
|
|
|
|
|
|
|-
|-
|Cauda Equina Neuroendocrine Tumour (Previously Paraganglioma)||Disease||
|Mesenchymal Chondrosarcoma||Disease||
|
|
|
|
|
|
|-
|-
|Meningioma||Disease||
|Chondrosarcoma||Disease||
|
|
|
|
|
|
|-
|-
|Solitary Fibrous Tumour||Disease||
|Chordoma||Disease||
|
|
|
|
|
|
|-
|-
|Haemangiomas and Vascular Malformations||Disease||
|Diffuse Meningeal Melanocytic Neoplasms: Melanocytosis and Melanomatosis||Disease||
|
|
|
|
|
|
|-
|-
|Haemangioblastoma||Disease||
|Circumscribed Meningeal Melanocytic Neoplasms: Melanocytoma and Melanoma||Disease||
|
|
|
|
|
|
|-
|-
|Rhabdomyosarcoma||Disease||
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease||
|
|
|
|
|
|
|-
|-
|Intracranial Mesenchymal Tumour, FET::CREB Fusion-Positive||Disease||
|Immunodeficiency-Associated CNS Lymphomas||Disease||
|
|
|
|
|
|
|-
|-
|CIC-Rearranged Sarcoma||Disease||
|Lymphomatoid Granulomatosis||Disease||
|
|
|
|
|
|
|-
|-
|Primary Intracranial Sarcoma, DICER1-Mutant||Disease||
|Intravascular Large B-cell Lymphoma||Disease||
|
|
|
|
|
|
|-
|-
|Ewing Sarcoma||Disease||
|MALT Lymphoma of the Dura||Disease||
|
|
|
|
|
|
|-
|-
|Mesenchymal Chondrosarcoma||Disease||
|Other Low-Grade B-cell Lymphomas of the CNS||Disease||
|
|
|
|
|
|
|-
|-
|Chondrosarcoma||Disease||
|Anaplastic Large Cell Lymphoma (ALK+/ALK−)||Disease||
|
|
|
|
|
|
|-
|-
|Chordoma||Disease||
|T-cell and NK/T-cell Lymphomas||Disease||
|
|
|
|
|
|
|-
|-
|Diffuse Meningeal Melanocytic Neoplasms: Melanocytosis and Melanomatosis||Disease||
|Erdheim-Chester Disease||Disease||
|
|
|
|
|
|
|-
|-
|Circumscribed Meningeal Melanocytic Neoplasms: Melanocytoma and Melanoma||Disease||
|Rosai-Dorfman Disease||Disease||
|
|
|
|
|
|
|-
|-
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease||
|Juvenile Xanthogranuloma||Disease||
|
|
|
|
|
|
|-
|-
|Immunodeficiency-Associated CNS Lymphomas||Disease||
|Langerhans Cell Histiocytosis||Disease||
|
|
|
|
|
|
|-
|-
|Lymphomatoid Granulomatosis||Disease||
|Histiocytic Sarcoma||Disease||
|
|
|
|
|
|
|-
|-
|Intravascular Large B-cell Lymphoma||Disease||
|Germ Cell Tumours of the CNS||Disease||
|
|
|
|
|
|
|-
|-
|MALT Lymphoma of the Dura||Disease||
|Adamantinomatous Craniopharyngioma||Disease||
|
|
|
|
|
|
|-
|-
|Other Low-Grade B-cell Lymphomas of the CNS||Disease||
|Papillary Craniopharyngioma||Disease||
|
|
|
|
|
|
|-
|-
|Anaplastic Large Cell Lymphoma (ALK+/ALK−)||Disease||
|Pituicytoma, Granular Cell Tumour of the Sellar Region, and Spindle Cell Oncocytoma||Disease||
|
|
|
|
|
|
|-
|-
|T-cell and NK/T-cell Lymphomas||Disease||
|Pituitary Adenoma/Pituitary Neuroendocrine Tumour||Disease||
|
|
|
|
|
|
|-
|-
|Erdheim-Chester Disease||Disease||
|Pituitary Blastoma||Disease||
|
|
|
|
|
|
|-
|-
|Rosai-Dorfman Disease||Disease||
|Metastases to the Brain and Spinal Cord Parenchyma||Disease||
|
|
|
|
|
|
|-
|-
|Juvenile Xanthogranuloma||Disease||
|Metastases to the Meninges||Disease||
|
|
|
|
|
|
|-
|-
|Langerhans Cell Histiocytosis||Disease||
|Neurofibromatosis Type 1||Disease||
|
|
|
|
|
|
|-
|-
|Histiocytic Sarcoma||Disease||
|Neurofibromatosis Type 2||Disease||
|
|
|
|
|
|
|-
|-
|Germ Cell Tumours of the CNS||Disease||
|Schwannomatosis||Disease||
|
|
|
|
|
|
|-
|-
|Adamantinomatous Craniopharyngioma||Disease||
|Von Hippel-Lindau Syndrome||Disease||
|
|
|
|
|
|
|-
|-
|Papillary Craniopharyngioma||Disease||
|Tuberous Sclerosis||Disease||
|
|
|
|
|
|
|-
|-
|Pituicytoma, Granular Cell Tumour of the Sellar Region, and Spindle Cell Oncocytoma||Disease||
|Li-Fraumeni Syndrome||Disease||
|
|
|
|
|
|
|-
|-
|Pituitary Adenoma/Pituitary Neuroendocrine Tumour||Disease||
|Cowden Syndrome||Disease||
|
|
|
|
|
|
|-
|-
|Pituitary Blastoma||Disease||
|Constitutional Mismatch Repair Deficiency Syndrome||Disease||
|
|
|
|
|
|
|-
|-
|Metastases to the Brain and Spinal Cord Parenchyma||Disease||
|Familial Adenomatous Polyposis 1||Disease||
|
|
|
|
|
|
|-
|-
|Metastases to the Meninges||Disease||
|Naevoid Basal Cell Carcinoma Syndrome||Disease||
|
|
|
|
|
|
|-
|-
|Neurofibromatosis Type 1||Disease||
|Rhabdoid Tumour Predisposition Syndrome||Disease||
|
|
|
|
|
|
|-
|-
|Neurofibromatosis Type 2||Disease||
|Carney Complex||Disease||
|
|
|
|
|
|
|-
|-
|Schwannomatosis||Disease||
|DICER1 Syndrome||Disease||
|
|
|
|
|
|
|-
|-
|Von Hippel-Lindau Syndrome||Disease||
|Familial Paraganglioma Syndromes||Disease||
|
|
|
|
|
|
|-
|-
|Tuberous Sclerosis||Disease||
|Melanoma-Astrocytoma Syndrome||Disease||
|
|
|
|
|
|
|-
|-
|Li-Fraumeni Syndrome||Disease||
|Familial Retinoblastoma||Disease||
|
|
|
|
|
|
|-
|-
|Cowden Syndrome||Disease||
|BAP1 Tumour Predisposition Syndrome||Disease||
|
|
|
|
|
|
|-
|-
|Constitutional Mismatch Repair Deficiency Syndrome||Disease||
|Fanconi Anaemia||Disease||
|
|
|
|
|
|
|-
|-
|Familial Adenomatous Polyposis 1||Disease||
|ELP1-Medulloblastoma Syndrome||Disease||
|
|
|
|
|
|
|-
|-
|Naevoid Basal Cell Carcinoma Syndrome||Disease||
|}<br />
|
==WHO Classification of Tumours of Breast Tumours (5th Edition) Content==
|
{| class="wikitable"
|
|-
|
!'''Disease'''!!'''Page Type'''!!'''Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|Adenoid Cystic Carcinoma
|Disease||Katherine Geiersbach
|10/12/02022
|
|
|PENDING
|
|
|Hui Chen
|
|
|2021 template added
|-
|-
|Rhabdoid Tumour Predisposition Syndrome||Disease||
|Secretory Carcinoma
|Disease
|Hui Chen
|10/12/2022
|
|PENDING
|
|Katherine Geiersbach
|
|2021 template added
|-
|}<br />
==WHO Classification of Tumours of Breast Tumours (5th Edition) Content==
{| class="wikitable"
|-
!'''Disease'''!!'''Page Type'''!!'''Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|- |Usual ductal hyperplasia||Disease||
|
|
|
|
|
|
|-
|-
|Carney Complex||Disease||
|Columnar Cell Lesions, Including Flat Epithelial Atypia||Disease||
|
|
|
|
|
|
|-
|-
|DICER1 Syndrome||Disease||
|Atypical Ductal Hyperplasia||Disease||
|
|
|
|
|
|
|-
|-
|Familial Paraganglioma Syndromes||Disease||
|Sclerosing Adenosis||Disease||
|
|
|
|
|
|
|-
|-
|Melanoma-Astrocytoma Syndrome||Disease||
|Apocrine Adenosis and Adenoma||Disease||
|
|
|
|
|
|
|-
|-
|Familial Retinoblastoma||Disease||
|Microglandular Adenosis||Disease||
|
|
|
|
|
|
|-
|-
|BAP1 Tumour Predisposition Syndrome||Disease||
|Radial Scar/Complex Sclerosing Lesion||Disease||
|
|
|
|
|
|
|-
|-
|Fanconi Anaemia||Disease||
|Tubular Adenoma||Disease||
|
|
|
|
|
|
|-
|-
|ELP1-Medulloblastoma Syndrome||Disease||
|Lactating Adenoma||Disease||
|
|
|
|
|
|
|-
|-
|}<br />
|Ductal Adenoma||Disease||
|
|Disease||Katherine Geiersbach
|10/12/02022
|
|
|
|
|
|
|
|
|
|
|
|
|-
|-
|Pleomorphic Adenoma||Disease||
|- |Usual ductal hyperplasia||Disease||
|
|
|
|
|
|
|-
|-
|Columnar cell lesions, including flat epithelial atypia||Disease||
|Adenomyoepithelioma||Disease||
|
|
|
|
|
|
|-
|-
|Atypical ductal hyperplasia||Disease||
|Malignant Adenomyoepithelioma||Disease||
|
|
|
|
|
|
|-
|-
|Sclerosing adenosis||Disease||
|Intraductal Papilloma||Disease||
|
|
|
|
|
|
|-
|-
|Apocrine adenosis and adenoma||Disease||
|Papillary Ductal Carcinoma In Situ||Disease||
|
|
|
|
|
|
|-
|-
|Microglandular adenosis||Disease||
|Encapsulated Papillary Carcinoma||Disease||
|
|
|
|
|
|
|-
|-
|Radial scar / complex sclerosing lesion||Disease||
|Solid Papillary Carcinoma (In Situ and Invasive)||Disease||
|
|
|
|
|
|
|-
|-
|Tubular adenoma||Disease||
|Invasive Papillary Carcinoma||Disease||
|
|
|
|
|
|
|-
|-
|Lactating adenoma||Disease||
|Atypical Lobular Hyperplasia||Disease||
|
|
|
|
|
|
|-
|-
|Ductal adenoma||Disease||
|Lobular Carcinoma In Situ||Disease||
|
|
|
|
|
|
|-
|-
|Pleomorphic adenoma||Disease||
|Ductal Carcinoma In Situ||Disease||
|
|
|
|
|
|
|-
|-
|Adenomyoepithelioma||Disease||
|Invasive breast carcinoma: General overview||Disease||????
|
|
|
|
|
|
|-
|-
|Malignant adenomyoepithelioma||Disease||
|Invasive Breast Carcinoma of No Special Type||Disease||
|
|
|
|
|
|
|-
|-
|Intraductal papilloma||Disease||
|Microinvasive Carcinoma||Disease||
|
|
|
|
|
|
|-
|-
|Papillary ductal carcinoma in situ||Disease||
|Invasive lobular Carcinoma||Disease||
|
|
|
|
|
|
|-
|-
|Encapsulated papillary carcinoma||Disease||
|Tubular Carcinoma||Disease||
|
|
|
|
|
|
|-
|-
|Solid papillary carcinoma (in situ and invasive)||Disease||
|Cribriform Carcinoma||Disease||
|
|
|
|
|
|
|-
|-
|Invasive papillary carcinoma||Disease||
|Mucinous Carcinoma||Disease||
|
|
|
|
|
|
|-
|-
|Atypical lobular hyperplasia||Disease||
|Mucinous Cystadenocarcinoma||Disease||
|
|
|
|
|
|
|-
|-
|Lobular carcinoma in situ||Disease||
|Invasive Micropapillary Carcinoma||Disease||
|
|
|
|
|
|
|-
|-
|Ductal carcinoma in situ||Disease||
|Carcinoma with Apocrine Differentiation||Disease||
|
|
|
|
|
|
|-
|-
|Invasive breast carcinoma: General overview||Disease||
|Metaplastic Carcinoma||Disease||
|
|
|
|
|
|
|-
|-
|Invasive breast carcinoma of no special type||Disease||
|Acinic Cell Carcinoma||Disease||
|
|
|
|
|
|
|-
|-
|Microinvasive carcinoma||Disease||
|Adenoid Cystic Carcinoma||Disease||
|
|
|
|
|
|
|-
|-
|Invasive lobular carcinoma||Disease||
|Secretory Carcinoma||Disease||
|
|
|
|
|
|
|-
|-
|Tubular carcinoma||Disease||
|Mucoepidermoid Carcinoma||Disease||
|
|
|
|
|
|
|-
|-
|Cribriform carcinoma||Disease||
|Polymorphous Adenocarcinoma||Disease||
|
|
|
|
|
|
|-
|-
|Mucinous carcinoma||Disease||
|Tall Cell Carcinoma with Reversed Polarity||Disease||
|
|
|
|
|
|
|-
|-
|Mucinous cystadenocarcinoma||Disease||
|Neuroendocrine Tumour||Disease||
|
|
|
|
|
|
|-
|-
|Invasive micropapillary carcinoma||Disease||
|Neuroendocrine Carcinoma||Disease||
|
|
|
|
|
|
|-
|-
|Carcinoma with apocrine differentiation||Disease||
|Hamartoma||Disease||
|
|
|
|
|
|
|-
|-
|Metaplastic carcinoma||Disease||
|Fibroadenoma||Disease||
|
|
|
|
|
|
|-
|-
|Acinic cell carcinoma||Disease||
|Phyllodes Tumour||Disease||
|
|
|
|
|
|
|-
|-
|Adenoid cystic carcinoma||Disease||
|Syringomatous Tumour||Disease||
|
|
|
|
|
|
|-
|-
|Secretory carcinoma||Disease||
|Nipple Adenoma||Disease||
|
|
|
|
|
|
|-
|-
|Mucoepidermoid carcinoma||Disease||
|Paget disease of the Breast||Disease||
|
|
|
|
|
|
|-
|-
|Polymorphous adenocarcinoma||Disease||
|Haemangioma||Disease||
|
|
|
|
|
|
|-
|-
|Tall cell carcinoma with reversed polarity||Disease||
|Angiomatosis||Disease||
|
|
|
|
|
|
|-
|-
|Neuroendocrine tumour||Disease||
|Atypical Vascular Lesions||Disease||
|
|
|
|
|
|
|-
|-
|Neuroendocrine carcinoma||Disease||
|Postradiation Angiosarcoma of the Breast||Disease||
|
|
|
|
|
|
|-
|-
|Hamartoma||Disease||
|Primary Angiosarcoma of the Breast||Disease||
|
|
|
|
|
|
|-
|-
|Fibroadenoma||Disease||
|Nodular Fasciitis||Disease||
|
|
|
|
|
|
|-
|-
|Phyllodes tumour||Disease||
|Myofibroblastoma||Disease||
|
|
|
|
|
|
|-
|-
|Syringomatous tumour||Disease||
|Desmoid Fibromatosis||Disease||
|
|
|
|
|
|
|-
|-
|Nipple adenoma||Disease||
|Inflammatory Myofibroblastic Tumour||Disease||
|
|
|
|
|
|
|-
|-
|Paget disease of the breast||Disease||
|Schwannoma||Disease||
|
|
|
|
|
|
|-
|-
|Haemangioma||Disease||
|Neurofibroma||Disease||
|
|
|
|
|
|
|-
|-
|Angiomatosis||Disease||
|Granular Cell Tumour||Disease||
|
|
|
|
|
|
|-
|-
|Atypical vascular lesions||Disease||
|Leiomyoma||Disease||
|
|
|
|
|
|
|-
|-
|Postradiation angiosarcoma of the breast||Disease||
|Leiomyosarcoma||Disease||
|
|
|
|
|
|
|-
|-
|Primary angiosarcoma of the breast||Disease||
|Lipoma||Disease||
|
|
|
|
|
|
|-
|-
|Nodular fasciitis||Disease||
|Angiolipoma||Disease||
|
|
|
|
|
|
|-
|-
|Myofibroblastoma||Disease||
|Liposarcoma||Disease||
|
|
|
|
|
|
|-
|-
|Desmoid fibromatosis||Disease||
|Pseudoangiomatous Stromal Hyperplasia||Disease||
|
|
|
|
|
|
|-
|-
|Inflammatory myofibroblastic tumour||Disease||
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)||Disease||
|
|
|
|
|
|
|-
|-
|Schwannoma||Disease||
|Follicular Lymphoma||Disease||
|
|
|
|
|
|
|-
|-
|Neurofibroma||Disease||
|Diffuse Large B-cell Lymphoma||Disease||
|
|
|
|
|
|
|-
|-
|Granular cell tumour||Disease||
|Burkitt Lymphoma||Disease||
|
|
|
|
|
|
|-
|-
|Leiomyoma||Disease||
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||
|
|
|
|
|
|
|-
|-
|Leiomyosarcoma||Disease||
|Gynaecomastia||Disease||
|
|
|
|
|
|
|-
|-
|Lipoma||Disease||
|Carcinoma In Situ||Disease||
|
|
|
|
|
|
|-
|-
|Angiolipoma||Disease||
|Invasive Carcinoma||Disease||
|
|
|
|
|
|
|-
|-
|Liposarcoma||Disease||
|Metastases to the Breast||Disease||
|
|
|
|
|
|
|-
|-
|Pseudoangiomatous stromal hyperplasia||Disease||
|BRCA1/2-Associated Hereditary Breast and Ovarian Cancer Syndrome||Disease||
|
|
|
|
|
|
|-
|-
|Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)||Disease||
|Cowden Syndrome||Disease||
|
|
|
|
|
|
|-
|-
|Follicular lymphoma||Disease||
|Ataxia-Telangiectasia||Disease||
|
|
|
|
|
|
|-
|-
|Diffuse large B-cell lymphoma||Disease||
|Li-Fraumeni Syndrome, TP53-Associated||Disease||
|
|
|
|
|
|
|-
|-
|Burkitt lymphoma||Disease||
|Li-Fraumeni Syndrome, CHEK2-Associated||Disease||
|
|
|
|
|
|
|-
|-
|Breast implant-associated anaplastic large cell lymphoma||Disease||
|CDH1-Associated Breast Cancer||Disease||
|
|
|
|
|
|
|-
|-
|Gynaecomastia||Disease||
|PALB2-Associated Cancers||Disease||
|
|
|
|
|
|
|-
|-
|Carcinoma in situ||Disease||
|Peutz-Jeghers Syndrome||Disease||
|
|
|
|
|
|
|-
|-
|Neurofibromatosis Type 1||Disease||
|Neurofibromatosis type 1||Disease||
|
|
|
|